ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

WSJ BLOG/Health: A.M. Vitals: Health-Care Overhaul Case Ripples Outward

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: Health Case Ripples Outward (WSJ): After three days of arguments over the constitutionality of the health-care overhaul, it's impossible to predict how the Supreme Court will rule, but skepticism from some justices heightens the possibility it could be overturned in June. Also: Three Days of Hearings Yield Five Take-Aways. Obesity-Linked Cancers Increase (WSJ): Overall cancer diagnoses in the U.S. have dropped, but several cancers linked to obesity and a sedentary lifestyle have risen each year from 1999 through 2008. Cancer: 'Book of Knowledge' Published (BBC): A large "encyclopedia" detailing how hundreds of different cancer cell lines interact with drugs that could speed development of new treatments was published in Nature. In Cancer Science, Many "Discoveries" Don't Hold Up (Reuters): Forty-seven of 53 "landmark" cancer studies from reputable labs couldn't be replicated, the former head of cancer research for Amgen said in a commentary piece in Nature, dimming the prospects for new drug development. FDA Asks Chelsea Therapeutics for More Data on Northera (Dow Jones Newswires): The FDA declined to approve Northera, a low-blood-pressure drug from Chelsea Therapeutics, saying additional data showing efficacy was required. Image source: iStockphoto -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/22/201517:40:50Amgen Ends Psoriasis-Drug Partnership With AstraZeneca
05/22/201516:22:00Amgen to terminate participation in co-development and commercialization...
05/22/201507:31:00Amgen Receives Positive CHMP Opinion For Use Of Repatha⢠(Evolocumab) F...
05/20/201512:15:10What Is the S&P 500 Index?
05/19/201511:36:02Forget MannKind Stock's Price: Here's What You Need to Focus...
05/18/201516:00:00Amgen Appoints Jonathan P. Graham Senior Vice President, General...
05/17/201509:05:022 Stocks With Jaw-Dropping Growth Potential
05/15/201506:06:00Current Report Filing (8-k)
05/15/201504:00:00Amgen Presents First Phase 2 Data For AMG 334 In The Prevention...
05/14/201517:58:00Amgen Announces Voting Results of Annual Meeting of Stockholders
05/13/201517:00:00Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio
05/13/201507:17:02The "Best of Breed" Dividend Stocks
05/12/201516:06:00Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide...
05/12/201510:26:025 Largest Markets for Pharmaceuticals
05/11/201516:58:04Statement of Changes in Beneficial Ownership (4)
05/11/201516:05:00Amgen To Present AMG 334 Data At 17th Congress of the International...
05/11/201511:40:11Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/08/201517:01:13Regeneron Earnings Shine, but All Eyes Are on the Pipeline
05/07/201513:40:20Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/07/201513:34:24Court Blocks Novartis Copy of Amgen Cancer-Care Drug

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad